Immunological Differences Between Immune-Rich Estrogen Receptor-Positive and Immune-Rich Triple-Negative Breast Cancers.

O'Meara, Tess; Marczyk, Michal; Qing, Tao; Yaghoobi, Vesal; Blenman, Kim; Cole, Kimberly; Pelekanou, Vasiliki; Rimm, David L; Pusztai, Lajos.

Afiliación

O'Meara T; Department of Medical Oncology, Yale School of Medicine, New Haven, CT.
Marczyk M; Department of Medical Oncology, Yale School of Medicine, New Haven, CT.
Qing T; Data Mining Division, Silesian University of Technology, Gliwice, Poland.
Yaghoobi V; Department of Medical Oncology, Yale School of Medicine, New Haven, CT.
Blenman K; Department of Pathology, Yale School of Medicine, New Haven, CT.
Cole K; Department of Medical Oncology, Yale School of Medicine, New Haven, CT.
Pelekanou V; Department of Pathology, Yale School of Medicine, New Haven, CT.
Rimm DL; Department of Pathology, Yale School of Medicine, New Haven, CT.
Pusztai L; Sanofi, Oncology and Translational Medicine, Bridgewater Township, NJ.

JCO Precis Oncol ; 42020.

Article en En | MEDLINE | ID: mdl-32923897

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: JCO Precis Oncol Año: 2020 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: JCO Precis Oncol Año: 2020 Tipo del documento: Article